Consumer Insights
Uncover trends and behaviors shaping consumer choices today
Procurement Insights
Optimize your sourcing strategy with key market data
Industry Stats
Stay ahead with the latest trends and market analysis.
Explore Our Diverse Range Of Offerings
From detailed reports to experts services offered in 15+
Industry Domains
Enoxaparin Sodium Pricing, Demand and Supply Overview
2025
Base Year
2023-2025
Historical Period
2026-2027
Forecast Period
Market Overview
In the United States, the highest-priced reporting region, enoxaparin sodium prices rose through 2025, climbing from USD 147,000/KG in Q1 to USD 154,500/KG by Q4, a gain of 5.1% as production costs and regulated-market demand firmed. The global average, which is heavily weighted by high-priced regulated markets, rose modestly from USD 72,825/KG to USD 73,775/KG over the year. For the remainder of 2026 a global average of USD 73,000-78,000/KG is expected. Prices vary enormously by regulatory market and grade, from bulk export active pharmaceutical ingredient near USD 11,000-25,000/KG to regulated-market levels above USD 100,000/KG.
Enoxaparin sodium is a low-molecular-weight heparin active pharmaceutical ingredient derived from heparin extracted from porcine intestinal mucosa, then depolymerised and fractionated, which ties its cost base to crude-heparin feedstock and complex regulated processing. Hospital use absorbs the largest share of demand, followed by outpatient and homecare anticoagulation, across thrombosis prevention and treatment. The key structural pricing drivers are crude-heparin feedstock availability, regulated-market demand for anticoagulant therapy, biosimilar and generic competition, quality and regulatory compliance, and active-ingredient export dynamics from major producing countries.
Enoxaparin Sodium Price Forecast for 2026
The supply and demand balance for enoxaparin sodium through the rest of 2026 looks firm in regulated markets and competitive in bulk-supply markets. Producer cost floors are supported because crude-heparin feedstock, sourced from porcine intestinal mucosa, is sensitive to pig-herd dynamics, while regulated demand for thrombosis therapy keeps growing with ageing populations. The main upside risk is crude-heparin feedstock tightness, a demand surge, or rising compliance costs. The main downside risk is biosimilar and generic price erosion in North America and Europe, ample crude-heparin supply, and substitution by direct oral anticoagulants in some treatment settings.
| Region | 2026 Price Range (USD/KG) | Outlook |
| Global Average | 73,000 - 78,000 | Firm in regulated markets against competitive bulk supply |
| United States | 155,000 - 168,000 | Regulated demand and production costs keep prices highest |
| Europe | 104,000 - 114,000 | Regulated demand against biosimilar competition |
| India | 24,500 - 27,500 | Active-ingredient export supply keeps prices competitive |
| China | 11,000 - 12,500 | Major raw-heparin and ingredient supply keeps prices lowest |
For the Quarter Ending March 2026
Enoxaparin Sodium Prices Q1 2026:
- United States: USD 157,000/KG
- Europe: USD 106,500/KG
- India: USD 25,300/KG
- China: USD 11,300/KG
Enoxaparin Sodium Prices in the United States
In Q1 2026 US enoxaparin sodium prices reached USD 157,000/KG, up 1.6% from USD 154,500/KG in Q4 2025 and the highest among the reporting regions. Steady demand from hospital anticoagulant procurement programs and consistent use in cardiovascular and surgical protocols supported the market, and rising production costs lifted the base. Structured active-ingredient sourcing and regulated supply-chain compliance shaped regional pricing, supporting the upward move across the quarter despite expanding generic competition.
Why did the price of Enoxaparin Sodium change in Q1 2026 in the United States?
Steady hospital demand and rising production costs lifted US prices 1.6% over the quarter. Regulated sourcing and compliance supported the move even as generic competition expanded.
Enoxaparin Sodium Prices in Europe
European enoxaparin sodium prices reached USD 106,500/KG in Q1 2026, up 1.9% from USD 104,500/KG in Q4 2025. Steady regulated-market demand for thromboprophylaxis supported the market, and improving availability of upstream biochemical intermediates eased the mid-year supply pressure. Firmer production and compliance costs lifted the base, and producers held firm pricing against biosimilar competition, supporting the upward move across the quarter.
Why did the price of Enoxaparin Sodium change in Q1 2026 in Europe?
Steady regulated demand and firmer production and compliance costs lifted European prices 1.9% over the quarter. Improving intermediate availability eased earlier supply pressure, supporting the move against biosimilar competition.
Enoxaparin Sodium Prices in India
Indian enoxaparin sodium prices reached USD 25,300/KG in Q1 2026, up 1.2% from USD 25,000/KG in Q4 2025. A modest recovery in active-ingredient export demand and balanced domestic pharmaceutical manufacturing supported the market, and firmer crude-heparin feedstock costs lifted the base. The country's competitive active-ingredient supply kept prices well below regulated Western markets, with the feedstock recovery driving a modest upward move across the quarter.
Why did the price of Enoxaparin Sodium change in Q1 2026 in India?
A modest export-demand recovery and firmer crude-heparin costs lifted Indian prices 1.2% over the quarter. Competitive active-ingredient supply kept the level well below regulated Western markets.
Enoxaparin Sodium Prices in China
Chinese enoxaparin sodium prices reached USD 11,300/KG in Q1 2026, up 1.8% from USD 11,100/KG in Q4 2025 while remaining the most competitive in the dataset. As a major supplier of raw heparin and active ingredient, China anchors the global floor, but firmer crude-heparin feedstock costs and measured export demand lifted the base. Sufficient upstream raw-heparin availability limited the rise, supporting a modest upward move across the quarter.
Why did the price of Enoxaparin Sodium change in Q1 2026 in China?
Firmer crude-heparin feedstock costs and measured export demand lifted Chinese prices 1.8% over the quarter. As a major raw-heparin supplier, ample availability kept the region the global floor.
For the Quarter Ending December 2025
Enoxaparin Sodium Prices Q4 2025:
- United States: USD 154,500/KG
- Europe: USD 104,500/KG
- India: USD 25,000/KG
- China: USD 11,100/KG
Enoxaparin Sodium Prices in the United States
In Q4 2025 US enoxaparin sodium prices reached USD 154,500/KG, a 2.3% rise from USD 151,000/KG in Q3 as hospital anticoagulant demand stayed firm and production costs rose. Consistent utilisation in cardiovascular treatment protocols supported the market, and structured active-ingredient sourcing shaped pricing. Regulated supply-chain compliance added cost, supporting a firm rise into the close of the year.
Why did the price of Enoxaparin Sodium change in Q4 2025 in the United States?
Firm hospital demand and rising production costs lifted US prices 2.3% over the quarter. Regulated sourcing and compliance costs supported the move into year-end.
Enoxaparin Sodium Prices in Europe
European enoxaparin sodium prices reached USD 104,500/KG in Q4 2025, a 1.0% rise from USD 103,500/KG in Q3 as availability of upstream biochemical intermediates improved off mid-year constraints. Steady regulated demand supported the market, and firmer production costs lifted the base. Producers held firm pricing against biosimilar competition, supporting a modest rise into the close of the year.
Why did the price of Enoxaparin Sodium change in Q4 2025 in Europe?
Improving intermediate availability and steady regulated demand lifted European prices 1.0% over the quarter. Firmer production costs supported the move against biosimilar competition.
Enoxaparin Sodium Prices in India
Indian enoxaparin sodium prices reached USD 25,000/KG in Q4 2025, a 2.0% decline from USD 25,500/KG in Q3 as moderated export volumes and balanced domestic manufacturing weighed. Competitive active-ingredient supply kept prices below regulated markets, and softer export demand pulled the market lower. Ample raw-heparin availability supported the easing into the close of the year.
Why did the price of Enoxaparin Sodium change in Q4 2025 in India?
Moderated export volumes and balanced domestic manufacturing eased Indian prices 2.0% over the quarter. Competitive active-ingredient supply kept the region well below regulated markets.
Enoxaparin Sodium Prices in China
Chinese enoxaparin sodium prices reached USD 11,100/KG in Q4 2025, a 0.9% rise from USD 11,000/KG in Q3 as measured export demand and steady production supported the market. Sufficient upstream raw-heparin availability influenced cost stability, and large active-ingredient supply kept the region the most competitive. Structured production planning supported a modest rise into the close of the year.
Why did the price of Enoxaparin Sodium change in Q4 2025 in China?
Measured export demand and steady production lifted Chinese prices 0.9% over the quarter. Ample raw-heparin availability kept the region the global floor.
Quarterly Enoxaparin Sodium Price Trends
Global enoxaparin sodium prices rose modestly across the six-quarter window, with the trend dominated by high-priced regulated markets. The blended average eased slightly from USD 72,825/KG in Q1 2025 to a mid-year level before firming to USD 73,775/KG in Q4 and USD 75,025/KG in Q1 2026, a net gain of 3.0% over the period. Firm regulated-market demand and rising production costs drove the increase, partly offset by softer bulk active-ingredient prices in major producing countries amid biosimilar and generic competition.
| Quarter | Price (USD/KG) | QoQ Change | Direction |
| Q1 2026 | 75,025 | +1.7% | ↑ Rising |
| Q4 2025 | 73,775 | +1.4% | ↑ Rising |
| Q3 2025 | 72,750 | +0.1% | - Stable |
| Q2 2025 | 72,675 | -0.2% | ↓ Falling |
| Q1 2025 | 72,825 | - | - Stable |
| Q2 2026 | In Progress | - | - In Progress |
What was Enoxaparin Sodium Price in 2025?
Enoxaparin sodium prices rose modestly through 2025, with the blended global average easing from USD 72,825/KG in Q1 to a mid-year low before firming to USD 73,775/KG in Q4, a net gain of 1.3%. Three forces defined the year. The first was firm regulated-market demand for anticoagulant therapy, reinforced by ageing populations and rising thromboembolic-disorder prevalence. The second was rising production and compliance costs in regulated markets. The third was softer bulk active-ingredient prices in major producing countries amid ample crude-heparin supply and biosimilar and generic competition.
Enoxaparin Sodium Prices in the United States in 2025
US prices rose from USD 147,000/KG in Q1 2025 to USD 154,500/KG by Q4, a gain of 5.1% and the highest level among the reporting regions. Firm hospital anticoagulant demand and rising production costs lifted the base through the year, and regulated supply-chain compliance added cost. Expanding generic competition tempered branded pricing only modestly. Regulated demand and production costs were the dominant annual influences.
Enoxaparin Sodium Prices in Europe in 2025
European prices eased modestly from USD 106,000/KG in Q1 2025 to USD 104,500/KG by Q4, a decline of 1.4%. Variable availability of upstream biochemical intermediates and biosimilar competition weighed through the middle of the year, with a late recovery on improving supply and firmer costs. Steady regulated demand supported the market. Supply variability and biosimilar competition were the dominant annual influences.
Enoxaparin Sodium Prices in India in 2025
Indian prices fell from USD 26,800/KG in Q1 2025 to USD 25,000/KG by Q4, a decline of 6.7%. Moderated export volumes and balanced domestic manufacturing weighed through the year, and competitive active-ingredient supply pulled prices lower. Ample raw-heparin availability supported the easing. Softer export demand was the dominant annual influence, keeping prices well below regulated markets.
Enoxaparin Sodium Prices in China in 2025
Chinese prices eased from USD 11,500/KG in Q1 2025 to USD 11,100/KG by Q4, a decline of 3.5% and the most competitive in the dataset. Measured export demand and ample raw-heparin availability weighed through the year, and deflationary pressure limited pricing power. As a major raw-heparin and active-ingredient supplier, China anchored the global floor. Ample supply and soft export demand were the dominant annual influences.
How We Can Help
Expert Market Research: Your Source for Real-Time Enoxaparin Sodium Price Intelligence
Expert Market Research delivers continuous enoxaparin sodium price tracking across regulated and bulk-supply markets, identifying not merely that prices moved but specifically why, tracing causation through crude-heparin feedstock availability, regulated-market demand for anticoagulant therapy, biosimilar and generic competition, quality and regulatory compliance, and active-ingredient export dynamics. The forecasts draw on feedstock economics, regulatory tracking, demand analysis, and supply-chain risk assessment across every reporting region, giving procurement teams a clear, forward-looking framework. Contact Expert Market Research today for enoxaparin sodium pricing data, bespoke market analysis, and strategic procurement advisory.
Key Questions Answered in the Report
It is a low-molecular-weight heparin anticoagulant used to prevent and treat thromboembolic disorders, including deep vein thrombosis and pulmonary embolism, and in acute coronary syndrome and surgical thromboprophylaxis. Hospital use takes the largest share, followed by outpatient and homecare settings.
The Q1 2026 blended global average was USD 75,025/KG, heavily weighted by high-priced regulated markets. The United States was the highest at USD 157,000/KG, while China was the most competitive at USD 11,300/KG on a bulk active-ingredient basis.
The blended global average rose modestly from USD 72,825/KG in Q1 2025 to USD 73,775/KG in Q4, a 1.3% net gain. Firm regulated demand and rising production costs drove the increase, partly offset by softer bulk active-ingredient prices.
Three factors shaped the year: firm regulated-market demand for anticoagulant therapy reinforced by ageing populations; rising production and compliance costs in regulated markets; and softer bulk active-ingredient prices amid ample crude-heparin supply and biosimilar competition.
The blended global average is forecast at USD 73,000-78,000/KG for the remainder of 2026. The range assumes firm regulated demand and crude-heparin feedstock sensitivity, with biosimilar erosion and alternative anticoagulants the key downside factors.
Prices range from bulk export active ingredient near USD 11,000-25,000/KG in major producing countries to regulated-market levels above USD 100,000/KG, reflecting differences in grade, regulatory approval, quality compliance and finished-supply positioning. The blended global average therefore sits between these very different price tiers.
This report is updated monthly. For real-time pricing intelligence, contact the Expert Market Research team directly.
Prices are driven mainly by crude-heparin feedstock availability, regulated-market demand and compliance costs, alongside biosimilar competition and export dynamics. Feedstock tightness, regulatory changes and generic price erosion can amplify moves across regions.
Enoxaparin sodium is derived from heparin extracted from porcine intestinal mucosa, so crude-heparin availability, sensitive to pig-herd dynamics, sets much of the cost base. Feedstock tightness lifts production costs, while ample crude-heparin supply, as seen in major producing countries, keeps bulk active-ingredient prices competitive.
Buyers can use the quarterly trend and forward forecast to time active-ingredient contracts, weigh bulk versus regulated-grade sourcing, and plan around crude-heparin feedstock cycles. Tracking regional differentials also helps balance competitive Asian active-ingredient supply against higher-cost regulated Western material, subject to quality and approval requirements.
Basic Report -
One Time
Basic Report -
Annual Subscription
Detailed Report -
One Time
Detailed Report -
Annual Subscription
Basic Report -
One Time
USD 799
tax inclusive*
- PDF Format
- 2-Years Historical Price Data
- Basic Visualizations And Trend Analysis
- Price Forecast (Next 6 Months)
- Summary Of Factors Influencing Prices
- News And Developments
- Monthly Report Updates
- Macroeconomic Factors And Their Impact
- Supply-Demand Analysis
- Insights From Government Data And Industry Bodies
- Analyst Support For Additional Insights
Basic Report -
Annual Subscription
USD 3,499
tax inclusive*
- PDF Format
- 2-Years Historical Price Data
- Basic Visualizations And Trend Analysis
- Price Forecast (Next 6 Months)
- Summary Of Factors Influencing Prices
- News And Developments
- Monthly Report Updates
- Macroeconomic Factors And Their Impact
- Supply-Demand Analysis (Quarterly)
- Insights From Government Data And Industry Bodies
- Analyst Support For Additional Insights
Detailed Report -
One Time
USD 4,299
tax inclusive*
- PDF Format
- 3-Years Historical Price Data
- Advanced Visualizations And In-Depth Trend Analysis
- Price Forecast (Next 2 Years)
- Comprehensive Analysis Of Factors Influencing Prices
- News And Developments
- Macroeconomic Factors And Their Impact
- Supply-Demand Analysis
- Insights From Government Data And Industry Bodies
- Monthly Report Updates
- Analyst Support For Additional Insights
Detailed Report -
Annual Subscription
USD 7,999
tax inclusive*
- PDF Format
- 3-Years Historical Price Data
- Advanced Visualizations And In-Depth Trend Analysis
- Price Forecast (Next 2 Years)
- Comprehensive Analysis Of Factors Influencing Prices
- News And Developments
- Monthly Report Updates
- Macroeconomic Factors And Their Impact
- Supply-Demand Analysis
- Insights From Government Data And Industry Bodies
- Analyst Support For Additional Insights
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Bundle Type
Flash Bundle
20% OFF
Number of Reports: 3
Small Business Bundle
25% OFF
Number of Reports: 5
Growth Bundle
30% OFF
Number of Reports: 8
Enterprise Bundle
35% OFF
Number of Reports: 10
Overview
- Life Time Access
- Analyst Support Related to Report
- PDF Version of the Report
- Complimentary Excel Data Set
- Free Analyst Hours
- Complimentary Free 1 Month Subscription to Trade Data Base
- Complimentary One Month Subscription to Price Database (Chemicals only)
- Complimentary PPT Version of the Report
- Complimentary License Upgrade
- Complimentary Power BI Dashboards
- Life Time Access
- Analyst Support Related to Report
- PDF Version of the Report
- Complimentary Excel Data Set
- Free Analyst Hours - 50 Hours
- Complimentary Free 1 Month Subscription to Trade Data Base
- Complimentary One Month Subscription to Price Database (Chemicals only)
- Complimentary PPT Version of the Report
- Complimentary License Upgrade
- Complimentary Power BI Dashboards
- Life Time Access
- Analyst Support Related to Report
- PDF Version of the Report
- Complimentary Excel Data Set
- Free Analyst Hours - 80 Hours
- Complimentary Free 1 Month Subscription to Trade Data Base
- Complimentary One Month Subscription to Price Database (Chemicals only)
- Complimentary PPT Version of the Report
- Complimentary License Upgrade
- Complimentary Power BI Dashboards
- Life Time Access
- Analyst Support Related to Report
- PDF Version of the Report
- Complimentary Excel Data Set
- Free Analyst Hours - 100 Hours
- Complimentary Free 1 Month Subscription to Trade Data Base
- Complimentary One Month Subscription to Price Database (Chemicals only)
- Complimentary PPT Version of the Report
- Complimentary License Upgrade
- Complimentary Power BI Dashboards
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Number of Reports: 3
20%
tax inclusive*
- 3 Reports Included
- Life Time Acess
- Analyst Support Related to Report
- PDF Version of the Report
- Free 1 Month Subscription to Trade Data Base
- 1 Month Subscription to Price Database (Chemicals only)
- Complimentary Excel Data Set
- PPT Version of the Report
- Power BI Dashboards
- License Upgrade
- Free Analyst Hours
Small Business Bundle
Number of Reports: 5
25%
tax inclusive*
- 5 Reports Included
- Life Time Acess
- Analyst Support Related to Report
- PDF Version of the Report
- Complimentary Excel Data Set
- Free Analyst Hours - 50 Hours
- Free 1 Month Subscription to Trade Data Base
- 1 Month Subscription to Price Database (Chemicals only)
- Complimentary Excel Data Set
- PPT Version of the Report
- Power BI Dashboards
- License Upgrade
Growth Bundle
Number of Reports: 8
30%
tax inclusive*
- 8 Reports Included
- Life Time Acess
- Analyst Support Related to Report
- PDF Version of the Report
- Complimentary Excel Data Set
- Free Analyst Hours - 50 Hours
- Free 1 Month Subscription to Trade Data Base
- 1 Month Subscription to Price Database (Chemicals only)
- License Upgrade
- Free Analyst Hours - 80 Hours
- Power BI Dashboards
Enterprise Bundle
Number of Reports: 10
35%
tax inclusive*
- 10 Reports Included
- Life Time Acess
- Analyst Support Related to Report
- PDF Version of the Report
- Complimentary Excel Data Set
- Free Analyst Hours - 50 Hours
- Free 1 Month Subscription to Trade Data Base
- 1 Month Subscription to Price Database (Chemicals only)
- License Upgrade
- Power BI Dashboards
- Free Analyst Hours - 100 Hours
How To Order
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Strategic Solutions for Informed Decision-Making
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.
